News

Dr Reddy’s Gemcitabine for Injection is the generic version of a cancer medication, Gemzar. Gemzar is indicated as a treatment for cancers of the pancreas, lung and breast

With this license extension application, the company is seeking marketing approval from the EMA for Zonegran as a monotherapy for patients suffering from epilepsy with partial seizures, with

The partnership allows INC to conduct research work on Debiopharm’s drug development project with the management of a clinical study. The partnership further agrees that the Debiopharm’s future

The study of two drugs which are mixed sigma-1 agonists are designed to assess their anti-amnesic and neuroprotective effects. The study includes a model to which oligomeric amyloid

PBS’ single-use bioreactors will be used for R&D and production by the Korean firms. PBS’ bioreactors, which employ a low shear Air Wheel mixing mechanism, are utilized to

Presently, the drug is being under investigation in a Phase II SHELTER study as a second-line treatment for advanced hepatocellular carcinoma and in SAPHIRE Phase II study, as

The funds are expected to be used for product development and for commercializing the company’s prebiotic products for the dietary supplement and health food markets. Prebiotics are non-digestible

PPD‘s net income was $45.42m, compared to $20.98m for the same period in the prior year. The company has posted operating income of $57.15m for the second quarter

As per the terms of the deal, Astellas is eligible to get an undisclosed upfront payment from Merck along with development, regulatory and sales milestone. Earlier, Cardiome Pharma